宫颈癌近距离治疗中Utrecht施源器的针使用与剂量学评估
研究分析22例宫颈癌患者近距离治疗中针的应用模式与剂量学结果,评估三分次计划标准可行性及针的必要性。平均每分次置入5.8根针、加载4.8根,CTVHR D90%平均处方剂量88.8 Gy(SD 4.2)EQD2₁₀,OAR限值均满足。去除中腹侧针后剂量分布差异极小,除非邻近GTVres。
要点
- 平均每分次置入5.8根针、加载4.8根,可满足小和大CTVHR三分次计划标准
- 中腹侧针在治疗计划中非必需,除非位于GTVres附近
- 中侧针置入和加载频率及强度最高
核心结论
- 平均每分次置入5.8根针可在三分次近距离治疗中满足小和大CTVHR的靶区与OAR计划标准
- 中腹侧针在治疗计划中非必需,除非位于GTVres附近
研究设计与样本
- 对22例宫颈癌患者分析实际置入与加载的针模式及剂量学结果
- 按CTVHR大小分组(<30 cm3为小,≥30 cm3为大)比较剂量学
- 从临床计划中去除置入最多但加载频率和强度最低的针后重新优化,比较重优化计划与临床计划
主要发现
- 平均每分次置入5.8根针、加载4.8根,平均加载强度22%(小CTVHR 17%,大CTVHR 29%)
- 中侧针置入和加载频率及强度最高
- CTVHR D90%平均处方剂量88.8 Gy(SD 4.2)EQD2₁₀,OAR平均限值得以满足
- 去除中腹侧针后重优化计划与临床计划剂量分布差异极小且具统计学意义
关键数值与推荐
- CTVHR D90%平均处方剂量88.8 Gy(SD 4.2)EQD2₁₀
- OAR平均限值得以满足
- 小CTVHR(<30 cm3)和大CTVHR(≥30 cm3)均满足计划标准
临床怎么用
- 宫颈癌近距离治疗中可平均每分次置入5.8根针以满足计划标准
- 中腹侧针可考虑省略,除非其位于GTVres附近
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To analyse the clinical use of needles and examine the feasibility to meet the planning criteria in three fractions of cervical cancer brachytherapy. Furthermore, to investigate whether the needles with the largest discrepancy between application and loading are essential to treatment planning. MATERIALS AND METHODS: For 22 patients we analysed the applied and loaded needle patterns, and examined the dosimetric results for small (<30 cm3) and large (≥30 cm3) CTVHR. We removed from the clinical plans (CP) the needles applied most, but with the lowest loading frequency and intensity and re-optimized these plans (RP). RESULTS: On average 5.8 needles were applied and 4.8 loaded per fraction, with average intensity 22% (17% for small, 29% for large CTVHR). Mid-lateral needles were applied and loaded most frequently and intensely. The average CTVHR D90% prescribed dose was 88.8 Gy (SD 4.2) EQD210, the average OAR [Formula: see text] limit was respected. Omitting the mid-ventral needles, minimal statistically significant differences were found in dose distributions between RP and CP. CONCLUSIONS: Applying on average 5.8 needles per fraction it was possible to meet the planning criteria for targets and OARs in three BT fractions for both small and large CTVHR. The mid-ventral needles were not essential in treatment planning, unless situated in the vicinity of the GTVres.
引用
- Smolic M, Sombroek C, Bloemers MCWM, et al. Needle use and dosimetric evaluation in cervical cancer brachytherapy using the Utrecht applicator. Radiother Oncol. 2017. PMID: 29198407. doi:10.1016/j.radonc.2017.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。